{"filings":[{"id":860998,"accession_number":"0001729149-26-000034","cik":1729149,"company_name":"VIEMED HEALTHCARE, INC.","ticker":"VMD","form_type":"8-K","filed_at":"2026-06-04T20:07:58+00:00","items":["5.02","5.07","9.01"],"status":"ready","headline":"Viemed Healthcare shareholders approve LTIP amendment, increase share reserve to 7.70M","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["LTIP share reserve increased to 7,696,717 shares, including up to 1M incentive stock options.","All seven directors elected; Sabrina Heltz received 79.76% support (20.24% withheld).","Say-on-pay advisory vote passed with 93.21% approval.","Ernst & Young LLP ratified as independent auditor for FY 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":368420000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":807997,"accession_number":"0001729149-26-000032","cik":1729149,"company_name":"VIEMED HEALTHCARE, INC.","ticker":"VMD","form_type":"8-K","filed_at":"2026-06-02T21:00:46+00:00","items":["7.01","9.01"],"status":"ready","headline":"Viemed Healthcare files investor presentation with no material updates","summary_kind":"llm","event_type":"other","confidence":"low","bullets":["Filed investor deck under Item 7.01 Regulation FD; no earnings or guidance provided.","Presentation includes standard disclaimers and overview of company as home-based clinical care provider.","No specific financial figures, new contracts, or operational milestones disclosed in the filing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":368420000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":95048,"accession_number":"0001729149-26-000028","cik":1729149,"company_name":"VIEMED HEALTHCARE, INC.","ticker":"VMD","form_type":"8-K","filed_at":"2026-05-05T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Viemed Healthcare reports Q1 2026 revenue of $75.4M, raises full-year guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenues increased 28% to $75.4 million for Q1 2026, up from $59.1 million in Q1 2025.","Adjusted EBITDA for Q1 2026 was $14.3 million, a 12% increase versus the prior year quarter.","Company repurchased 150,000 common shares at an average price of $9.29 per share during Q1.","Ventilator patient count reached 12,089; PAP therapy patient count grew 57% to 35,938 as of March 31.","Full-year 2026 net revenue guidance raised to $312–$320 million from prior $310–$320 million."],"consensus_eps_estimate":null,"consensus_eps_actual":0.06,"consensus_revenue_estimate":null,"consensus_revenue_actual":75414000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":368420000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":107837,"accession_number":"0001729149-26-000011","cik":1729149,"company_name":"VIEMED HEALTHCARE, INC.","ticker":"VMD","form_type":"8-K","filed_at":"2026-03-16T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Viemed files March 2026 investor deck with no material new data disclosed","summary_kind":"llm","event_type":"other","confidence":"low","bullets":["Investor deck titled 'A Rapidly Growing National Leader In Home-Based Clinical Care' filed as Exhibit 99.1.","Deck available on company website; no specific financial or operational updates provided in the filing text.","Presentation is furnished under Regulation FD and not deemed filed for SEC liability purposes."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":368420000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":107836,"accession_number":"0001729149-26-000008","cik":1729149,"company_name":"VIEMED HEALTHCARE, INC.","ticker":"VMD","form_type":"8-K","filed_at":"2026-03-04T23:59:59+00:00","items":["2.02","7.01","8.01","9.01"],"status":"ready","headline":"Viemed posts record FY2025 revenue $270.3M; net income +33%; guides FY2026 rev $310-320M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $76.2M (record, +26% YoY); FY revenue $270.3M (record, +21% YoY).","FY2025 net income $14.9M ($0.37 diluted EPS), +33% YoY; adjusted EBITDA record $61.4M.","FY2025 operating cash flow $51.9M; free cash flow $28.1M (more than doubled YoY).","2026 guidance: revenue $310-320M, adjusted EBITDA $65-69M, capex 10-11.5% of revenue.","Board authorized share repurchase of up to 1,930,131 shares (~5% outstanding) through March 2027."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":368420000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":124233,"accession_number":"0001729149-25-000151","cik":1729149,"company_name":"VIEMED HEALTHCARE, INC.","ticker":"VMD","form_type":"8-K","filed_at":"2025-11-07T23:59:59+00:00","items":["1.01","7.01","9.01"],"status":"ready","headline":"Viemed extends delayed draw term loan commitment to Nov 2026 and furnishes investor presentation","summary_kind":"llm","event_type":"debt","confidence":"low","bullets":["Amendment extends delayed draw term loan commitment expiration from Nov 29, 2025 to Nov 29, 2026.","Other technical amendments made to the credit agreement with Regions Bank.","Company furnished November 2025 investor presentation; specific financial data not available in excerpt."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":368420000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":124232,"accession_number":"0001729149-25-000148","cik":1729149,"company_name":"VIEMED HEALTHCARE, INC.","ticker":"VMD","form_type":"8-K","filed_at":"2025-11-05T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Viemed Q3 revenue record $71.9M, up 24% YoY; guides FY rev $271-273M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenues $71.9M, a company record, up 24% YoY from $58.0M.","Net income $3.5M ($0.09 diluted EPS); adjusted EBITDA $16.1M, up 15.5% YoY.","Patient counts: ventilators 12,372 (+8.8% YoY); PAP therapy 31,891 (+63.7% YoY); sleep resupply 33,518 (+51.4% YoY).","Closed Lehan's Medical Equipment acquisition July 1, immediately accretive. Repurchased 1.7M shares at avg $6.68.","FY 2025 guidance: revenue $271-273M (prior $271-277M); adjusted EBITDA $60-62M (prior $59-62M)."],"consensus_eps_estimate":null,"consensus_eps_actual":0.23,"consensus_revenue_estimate":null,"consensus_revenue_actual":194099000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":368420000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":140905,"accession_number":"0001729149-25-000142","cik":1729149,"company_name":"VIEMED HEALTHCARE, INC.","ticker":"VMD","form_type":"8-K","filed_at":"2025-09-23T23:59:59+00:00","items":["7.01","8.01","9.01"],"status":"ready","headline":"Viemed completes $13.2M share buyback of 1.98M shares (5% of outstanding)","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Repurchased 1,976,441 common shares for approximately $13.2M at weighted average price of $6.69 per share.","Represents approximately 5% of total issued and outstanding shares as of June 9, 2025 authorization date.","All repurchases completed in open market transactions by September 23, 2025.","CEO states strong balance sheet and rising free cash flow support growth and capital returns."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":368420000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":140904,"accession_number":"0001729149-25-000118","cik":1729149,"company_name":"VIEMED HEALTHCARE, INC.","ticker":"VMD","form_type":"8-K","filed_at":"2025-08-06T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Viemed Q2 net revenue $63.1M (record, +14.7% YoY); diluted EPS $0.08 vs $0.04","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenues for Q2 2025 hit $63.1M, a record high, up 14.7% from $55.0M in Q2 2024.","Net income attributable to Viemed $3.2M ($0.08 diluted EPS) vs $1.5M ($0.04) YoY, +115.1%.","Adjusted EBITDA $14.3M, up 11.5% over the prior year quarter."],"consensus_eps_estimate":null,"consensus_eps_actual":0.14,"consensus_revenue_estimate":null,"consensus_revenue_actual":122185000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":368420000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":140903,"accession_number":"0001729149-25-000112","cik":1729149,"company_name":"VIEMED HEALTHCARE, INC.","ticker":"VMD","form_type":"8-K","filed_at":"2025-07-02T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Viemed closes acquisition of Lehan's Medical Equipment for $26M base plus $2.2M earnout","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Base purchase price $26M (subject to adjustments) plus estimated contingent consideration of ~$2.2M.","Lehan's 2024 net revenues ~$25.7M and Adjusted EBITDA ~$7.4M.","CEO cites Lehan's 80-year track record and preferred contracts to expand patient reach.","Viemed expects to update FY2025 guidance to reflect acquisition when reporting Q2 2025 earnings."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":368420000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":158664,"accession_number":"0001729149-25-000101","cik":1729149,"company_name":"VIEMED HEALTHCARE, INC.","ticker":"VMD","form_type":"8-K","filed_at":"2025-06-09T23:59:59+00:00","items":["1.01","8.01","7.01","9.01"],"status":"ready","headline":"Viemed authorizes share repurchase of up to 1.98M shares (~5% of outstanding) through June 2026","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Board authorized repurchase of up to 1,976,441 common shares (approx. 5% of outstanding) through June 2026.","Company has no net debt and full $55M credit facility available to fund repurchases and growth.","CEO cited strong Q1 2025 results, increased 2025 guidance, and disciplined capital allocation.","Acquisition of Lehan's Medical expected to close in Q3 2025; company repurchased ~2.6M shares since listing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":368420000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":158663,"accession_number":"0001729149-25-000098","cik":1729149,"company_name":"VIEMED HEALTHCARE, INC.","ticker":"VMD","form_type":"8-K","filed_at":"2025-06-05T23:59:59+00:00","items":["5.02","5.07","9.01"],"status":"ready","headline":"Shareholders approve amendment to 2024 LTIP, increasing share pool to ~7.9M","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Amendment increases maximum shares available under 2024 LTIP to 7,904,769.","Minimum one-year vesting period established for all awards, with limited exceptions.","Change in control vesting clarified: full acceleration if termination without cause or good reason within one year after CIC.","All seven director nominees elected with >90% support; Ernst & Young reappointed as auditor.","Advisory say-on-pay and 1-year frequency votes passed with >97% approval."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":368420000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":158662,"accession_number":"0001729149-25-000095","cik":1729149,"company_name":"VIEMED HEALTHCARE, INC.","ticker":"VMD","form_type":"8-K","filed_at":"2025-05-07T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Viemed reports Q1 2025 revenue of $59.1M, up 17% YoY; net income rises 64%","summary_kind":"llm","event_type":"earnings","confidence":"medium","bullets":["Q1 net revenues $59.1M, 17% increase from $50.6M in Q1 2024.","Net income $2.6M ($0.06 diluted EPS) vs $1.6M ($0.04) prior year, up 64%.","Adjusted EBITDA $12.8M, 26% higher than $10.2M in Q1 2024.","Company provided updated full-year 2025 guidance alongside Q1 results."],"consensus_eps_estimate":null,"consensus_eps_actual":0.06,"consensus_revenue_estimate":null,"consensus_revenue_actual":59129000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":368420000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":158661,"accession_number":"0001729149-25-000086","cik":1729149,"company_name":"VIEMED HEALTHCARE, INC.","ticker":"VMD","form_type":"8-K","filed_at":"2025-05-06T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Viemed acquires Lehan's Medical Equipment for $26M base price; diversifies into women's health","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Base purchase price $26M, plus ~$2.2M contingent payments; expected close Q3 2025.","Lehan generated 2024 net revs ~$25.7M and Adj. EBITDA ~$7.4M.","Acquisition diversifies into women's health/maternal health; Lehan has 6 locations, 90+ employees.","CEO Casey Hoyt says acquisition provides strong platform for growth diversification."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":368420000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":158660,"accession_number":"0001729149-25-000067","cik":1729149,"company_name":"VIEMED HEALTHCARE, INC.","ticker":"VMD","form_type":"8-K","filed_at":"2025-04-14T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Bruce Greenstein resigns from Viemed Healthcare board effective April 14, 2025","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Resignation was effective immediately; no replacement has been announced.","Greenstein served as Chairman of the Corporate Governance & Nominating Committee and as a member of the Audit Committee.","Company states resignation did not result from any disagreement with the board or management.","Director departure follows an orderly process; no operational or policy disputes cited."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":368420000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":177057,"accession_number":"0001729149-25-000062","cik":1729149,"company_name":"VIEMED HEALTHCARE, INC.","ticker":"VMD","form_type":"8-K","filed_at":"2025-03-18T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Viemed posts March 2025 investor presentation; no specific financial updates in filing","summary_kind":"llm","event_type":"other","confidence":"low","bullets":["Company furnished an investor deck covering home respiratory care leadership and business overview.","No quarterly earnings, guidance changes, or material operational metrics disclosed in the presentation excerpt.","Deck is available on Viemed's investor relations website and may be used in meetings with investors.","Filing does not contain new financial data or forward-looking adjustments beyond prior disclosures."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":368420000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":177056,"accession_number":"0001729149-25-000055","cik":1729149,"company_name":"VIEMED HEALTHCARE, INC.","ticker":"VMD","form_type":"8-K","filed_at":"2025-03-10T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Viemed posts record Q4 revenue $60.7M; full year net revenue $224.3M; issues 2025 guidance","summary_kind":"llm","event_type":"earnings","confidence":"medium","bullets":["Q4 net revenue $60.7M (+20% YoY); full year $224.3M (+23% YoY).","Q4 diluted EPS $0.10 (net income $4.3M); full year EPS $0.28.","Adjusted EBITDA Q4 $14.2M; full year record $51.1M.","Ventilator patients 11,795 (+14% YoY); PAP therapy 21,338 (+43% YoY).","Issued fiscal 2025 guidance; specific targets not included in filing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":368420000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":193835,"accession_number":"0001729149-24-000213","cik":1729149,"company_name":"VIEMED HEALTHCARE, INC.","ticker":"VMD","form_type":"8-K","filed_at":"2024-11-12T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Viemed files investor presentation; no specific financial details provided in filing","summary_kind":"llm","event_type":"other_material","confidence":"low","bullets":["Furnished an investor presentation (Exhibit 99.1) under Item 7.01.","Presentation dated November 2024, intended for investor meetings.","No new material financial data or guidance included in the filing text.","Presentation available on company website."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":368420000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":193834,"accession_number":"0001729149-24-000209","cik":1729149,"company_name":"VIEMED HEALTHCARE, INC.","ticker":"VMD","form_type":"8-K","filed_at":"2024-11-06T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Viemed Healthcare Q3 2024: revenue up 17.4% to $58M, net income up 33%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenues of $58.0M, a company record; up 17.4% YoY and 5.5% sequentially.","Net income rose 33% to $3.9M ($0.10 diluted EPS); adjusted EBITDA up 15.5% to $14.0M.","Non-acquired net revenues increased 15% YoY, excluding $1.1M from acquisitions."],"consensus_eps_estimate":null,"consensus_eps_actual":0.17,"consensus_revenue_estimate":null,"consensus_revenue_actual":163562000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":368420000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":210166,"accession_number":"0001729149-24-000170","cik":1729149,"company_name":"VIEMED HEALTHCARE, INC.","ticker":"VMD","form_type":"8-K","filed_at":"2024-08-14T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Viemed furnishes August 2024 investor deck; no material new disclosures","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Presentation provides general business overview and strategy for home respiratory care.","No new financial results, guidance, or operational metrics were disclosed.","Deck is available on company's website and will be used in investor meetings.","Forward-looking statements and risk factors included; historical data unchanged."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":368420000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":210165,"accession_number":"0001729149-24-000160","cik":1729149,"company_name":"VIEMED HEALTHCARE, INC.","ticker":"VMD","form_type":"8-K","filed_at":"2024-08-07T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Viemed Q2 2024 revenue hits record $55.0M, up 27% YoY; Adjusted EBITDA up 31%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenues $55.0M (record), up 27% YoY and 9% sequential from Q1 2024.","Net income $1.5M for Q2 2024.","Adjusted EBITDA $12.8M, a 31% increase over Q2 2023.","Company reports strong growth in respiratory care and home medical equipment services."],"consensus_eps_estimate":null,"consensus_eps_actual":0.08,"consensus_revenue_estimate":null,"consensus_revenue_actual":105558000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":368420000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":228425,"accession_number":"0001729149-24-000152","cik":1729149,"company_name":"VIEMED HEALTHCARE, INC.","ticker":"VMD","form_type":"8-K","filed_at":"2024-06-06T23:59:59+00:00","items":["5.02","5.07","9.01"],"status":"ready","headline":"Viemed shareholders approve 2M-share 2024 LTIP; directors elected with notable withhold votes","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Shareholders approved 2024 Long Term Incentive Plan authorizing up to 2,000,000 common shares for equity awards.","Plan passed with 69.21% for, 30.79% against (excluding 4,302,487 broker non-votes).","Eight directors elected; Bruce Greenstein had highest withhold at 18.61%, followed by Nitin Kaushal (15.58%) and Timothy Smokoff (13.74%).","Appointment of Ernst & Young as auditors ratified with 99.67% for.","Broker non-votes of 4,302,487 on director elections and plan vote."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":368420000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":228424,"accession_number":"0001729149-24-000148","cik":1729149,"company_name":"VIEMED HEALTHCARE, INC.","ticker":"VMD","form_type":"8-K","filed_at":"2024-05-29T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Viemed Healthcare extends delayed draw term loan commitment to Nov 2025","summary_kind":"llm","event_type":"debt","confidence":"low","bullets":["Extended delayed draw term loan commitment expiration from May 29, 2024 to November 29, 2025.","Amendment entered by Viemed, Inc. and subsidiaries with Regions Bank as administrative agent.","Includes unspecified technical amendments; no new borrowing or amount change disclosed.","Original Credit Agreement dated November 29, 2022; full terms in Exhibit 10.1."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":368420000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":228423,"accession_number":"0001729149-24-000123","cik":1729149,"company_name":"VIEMED HEALTHCARE, INC.","ticker":"VMD","form_type":"8-K","filed_at":"2024-05-09T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Viemed furnishes May 2024 investor deck; no specific new financial data provided in exhibit","summary_kind":"llm","event_type":"other_material","confidence":"low","bullets":["Filing is a Regulation FD disclosure of an investor presentation used for meetings.","Exhibit 99.1 is labeled as 'Investor Presentation May 2024' but contains only disclaimers.","No financial metrics, guidance updates, or operational figures are extractable from the filing.","The presentation is available on the company's website; no material change disclosed."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.0,"calibrated_materiality_score":0.0,"market_cap_usd":368420000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":228422,"accession_number":"0001729149-24-000101","cik":1729149,"company_name":"VIEMED HEALTHCARE, INC.","ticker":"VMD","form_type":"8-K","filed_at":"2024-05-06T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Viemed Q1 2024 revenue $50.6M, up 28% YoY; net income $1.6M","summary_kind":"llm","event_type":"earnings","confidence":"medium","bullets":["Net revenues $50.6M for Q1 2024, increase of $11.0M or 28% vs Q1 2023.","Net income $1.6M; Adjusted EBITDA $10.1M, up 21% YoY.","Operational highlights include strong growth in respiratory care and HME services."],"consensus_eps_estimate":null,"consensus_eps_actual":0.04,"consensus_revenue_estimate":null,"consensus_revenue_actual":50593000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":368420000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":228421,"accession_number":"0001729149-24-000088","cik":1729149,"company_name":"VIEMED HEALTHCARE, INC.","ticker":"VMD","form_type":"8-K","filed_at":"2024-04-02T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Viemed acquires majority stake in East Alabama HomeMed; expects ~$4M annual revenue","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Transaction closed April 1, 2024; Viemed gains controlling interest and managerial control of HomeMed.","East Alabama Health (EAH) retains minority non-controlling interest; partnership with 380-physician network.","Incremental annualized revenue expected approximately $4 million from acquired operations.","CEO Casey Hoyt says this is a replicable blueprint for hospital joint ventures."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":368420000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":247120,"accession_number":"0001729149-24-000079","cik":1729149,"company_name":"VIEMED HEALTHCARE, INC.","ticker":"VMD","form_type":"8-K","filed_at":"2024-03-11T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Viemed files March 2024 investor deck with no specific new financial targets disclosed","summary_kind":"llm","event_type":"other_material","confidence":"low","bullets":["Company posted slide deck to investors covering home respiratory care market position.","No earnings, guidance, or transaction numbers included in the exhibit portion provided.","Presentation filed as Exhibit 99.1 under Regulation FD; deck available on company website."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":368420000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":247119,"accession_number":"0001729149-24-000075","cik":1729149,"company_name":"VIEMED HEALTHCARE, INC.","ticker":"VMD","form_type":"8-K","filed_at":"2024-03-06T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Viemed reports record Q4 revenue $50.7M (+35% YoY); net income up 43%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 2023 revenue $50.7M, up 35% from $37.5M in Q4 2022; full-year revenue $183.0M, up 32%.","Q4 net income $3.5M (+43% YoY); full-year net income $10.2M (+65% YoY), seventh consecutive profitable year.","Adjusted EBITDA for Q4 $12.8M; full-year record $43.1M.","Company highlights record quarterly and annual net revenues driven by respiratory care services growth."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":368420000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}